ALDER THERAPEUTICS

Alder Therapeutics secured 20 MSEK seed financing from two top tier Swedish life-science investors Flerie Invest AB and Linc AB (publ). Upon reaching certain development milestones, Alder will receive an additional 14.4 MSEK. The proceeds will be used to develop two of Alder's initial stem cell therapy programs and to build the team to drive these programs forward... Cell therapy has taken a long time to evolve. In cell therapy the main challenge is to find the optimal manufacturing process that delivers the best therapeutic cells every single time. The Alder Edge helps to optimize pluripotent stem cell differentiation processes, delivering more homogeneous and highest quality cell therapy products, every single time... 17 th January 2023, Stockholm, Sweden. In two separate exclusive license agreements, Alder Therapeutics AB secured access to Intellectual Property and know-how for two state-of-the-art methods to manufacture retinal and cardiac cell therapeutic products.

Also known as: Alder